ArticlePloS one2015

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults.

Sharon Sheehan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.